Effect of selenium on lipid profile, Weight gain and Physical Activity in hemodialysis patients
Not Applicable
- Conditions
- End stage renal disease.Chronic kidney disease, stage 5N18.5
- Registration Number
- IRCT20190622043973N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
At least 6 months passing after hemodialysis starting
The patient's willingness to cooperate
Exclusion Criteria
Hepatitis
Skeletal disorder
Steroidal and non-steroidal anti-inflammatory drugs within two months before the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum triglyceride levels. Timepoint: Before starting the study and 3 months after the intervention began. Method of measurement: Autoanalyser.;Total serum cholesterol level. Timepoint: Before starting the study and 3 months after the intervention began. Method of measurement: Autoanalyser.;Weighing. Timepoint: Before starting the study and 3 months after the intervention began. Method of measurement: Scale.;Physical activity. Timepoint: Before starting the study and 3 months after the intervention began. Method of measurement: Five times sit to stand test.
- Secondary Outcome Measures
Name Time Method